Sustainable EPA Opportunity AlgiSys offers an environmentally sustainable EPA omega-3 source derived from microalgae, providing a compelling alternative to fish oil for nutraceuticals, aquaculture, and animal nutrition. This positions sales efforts to target customers seeking greener supply chains and verified sustainability claims.

Strategic Partnerships Recent and ongoing collaborations with Edinburgh Napier University, Clean Food Group, and cross-border partners at Aqua Nor highlight a strong network for co-development, validation, and market entry. Targeted outreach to research institutions, ingredient manufacturers, and distributors could unlock joint ventures and licensing deals.

Global Expansion Signals Historical plans for Saudi Arabia facility expansion and MOUs with the Saudi Ministry of Investment indicate appetite for large-scale production and regional partnerships. Sales opportunities may lie in regional food, feed, and pharmaceutical markets seeking local EPA and DHA supply.

Diversified Product Use Patented algal technology supports EPA omega-3 and plant protein ingredients across multiple industries, including aquaculture, supplements, food & beverage, cosmetics, and pet nutrition. A multi-sector sales approach can maximize wallet share by tailoring formulations to each vertical.

Financial Readiness With reported revenue between one and ten million and total funding of nearly nine million, AlgiSys demonstrates growth potential and investment credibility. This can ease pilot program discussions, co-development grants, and scaled production commitments with potential buyers seeking demonstrable ROI.